Management

President, Co-Founder & Board Director — Thomas Forest Farb-Horch

Serial life sciences & technology executive, founder, and Board Member at Cytyc, Fair Isaac Corporation (FICO), HNC Software, Indevus Pharmaceuticals, Retek and Saf-T-Med. (email tom.farb@thrivebio.com) LinkedIn Profile

CSO, Co-Founder & Board Director — Alan Blanchard, Ph.D.

Numerous commercial instrumentation successes in DNA sequencing & DNA microarrays at Life Technologies, Applied Biosystems, Agencourt Personal Genomics & Rosetta Inpharmatics. B.S. & Ph.D., California Institute of Technology & postdoctoral fellowship with Lee Hood. Seven issued patents. (email alan.blanchard@thrivebio.com) LinkedIn Profile

VP, Engineering & Manufacturing — Jeff Goldman, M.S.

Senior management and senior product development roles at Seahorse Bioscience (acquired by Agilent), 454 Life Sciences (acquired by Roche Diagnostics), MJ Research (acquired by Bio-Rad), Gamera Bioscience (acquired by Tecan). M.S. University of Virginia, B.S. Colgate University. (email jeff.goldman@thrivebio.com) LinkedIn Profile

EVP, Commercialization — Herb Kenny

Former VP of Commercial Operations, Scientific Instruments, Thermo Fisher Scientific ($2 billion of sales) and VP of Global Sales, Scientific Instruments, Thermo Fisher Scientific.
(email herb.kenny@thrivebio.com) LinkedIn Profile

EVP, International —Takashi Kiyoizumi, M.D., Ph.D., M.B.A.

Founder and CEO, MediciNova (NASDAQ: MNOV). President and CEO, Tanabe Research Laboratories, USA, US affiliate of Mitsubishi Tanabe Pharma. M.D. & Ph.D. from Keio School of Medicine and M.B.A from MIT.
(email takashi.kiyoizumi@thrivebio.com) LinkedIn Profile

VP, Intellectual Property — Ira Schaefer, J.D.

Former Partner at Hogan Lovells, Clifford Chance and Chadbourne & Parke.
(email ira.schaefer@thrivebio.com) LinkedIn Profile

Outside Board of Directors

Guy Broadbent, Chairperson

President, Vector Advisors; Previously CEO, Argotec (acquired by Schweitzer-Mauduit); President, Thermo Fisher Scientific, Laboratory Products Group; CEO, XcellereX (acquired by GE Life Sciences). Chairperson at Aquapak Polymers and Clock Spring|NRI. Member of Board of Directors at Advanced Instruments, Aurora Plastics, Paragon Films & Radical Plastics. LinkedIn Profile 

Michael Finney, Ph.D., Director

Managing Director, Finney Capital; Previously Co-founder & CSO, MJ Research; CEO, Vaxart; Member of Board of Directors at Genome Partnership, Innerscope Research, Orion Genomics, Sage Science & Vaxart. Ph.D., Massachusetts Institute of Technology, Biology.  LinkedIn Profile

Brock C. Reeve, M.Phil., M.B.A., Director

Executive Director, Harvard Stem Cell Institute and CEO, IVIVA Medical. Previously Managing Director & COO, Life Science Insights, an IDC Company; Healthcare Practice Director, Viant Corp.; Principal, SRI Consulting. M.Phil, Yale; MBA, Harvard Business School.  LinkedIn Profile

Advisory Board

Stephen Fantone, Ph.D. (Optics)

  • Founder & CEO, Optikos Corporation
  • Director, American Optical Society
  • MIT, University of Rochester (Ph.D.)

Stan Lapidus (Diagnostics)

  • Founder & CEO of SynapDx, Helicos, Exact Labs, Cytyc
  • Cooper Union

James Sherley, M.D., Ph.D. (Stem Cells)

  • Founder, Asymmetrex
  • Former Director, Adult Stem Cell Technology Center
  • Johns Hopkins Medical School (M.D., Ph.D.)

Jerry Karabelas, Ph.D. (Drug Development/VC)

  • Partner of Care Capital, LLC
  • Ex-CEO of Novartis
  • UNH, Massachusetts College of Pharmacy (Ph.D.)

Sung Joo Lee, Ph.D. (Korea; Therapeutics)

  • CEO of Orum Therapeutics
  • Head of Asia Pacific R&D, Sanofi
  • Yonsei University, University of California, Berkeley (Ph.D.)
  • Stanford University (Post Doctoral Scholar)

Dan Marshak, Ph.D. (Instrumentation; Stem Cells)

  • Ex-CSO of PerkinElmer
  • Ex-VP of R&D & CTO of Cambrex Corp
  • Harvard; Rockefeller (Ph.D.)

Bobby Sandage, Ph.D. (Therapeutics)

  • CEO of Euclises Pharmaceuticals
  • General Partner, Cultivation Capital Life Sciences Fund
  • University of Arkansas, Purdue (Ph.D.)

Sadashi Suzuki, L.L.B., MBA (Japan; Sales & Marketing)

  • President, Bio-Rad Laboratories, K.K.
  • General Manager – Japan, Affymetrix
  • Waseda (L.L.B.); Northwestern (MBA)

Derek Yoon (US/Korea; VC)

  • CEO of Solasta Ventures (formerly AJU IB Investment)
  • Portfolio Manager, Healthcare Banking, RBS Citizens
  • Babson (MBA); Boston College (MSF)